| Study of Preoperative Chemotherapy for Early Triple Negative or HER2-positive Operable Breast Cancer (NCT02934828) | Chinese Academy of Medical Sciences | 2014-10-01 |
| A Study to Assess Safety and PK of Liquid Alpha₁-Proteinase Inhibitor (Human) in Treating Alpha₁-Antitrypsin Deficiency (NCT02282527) | Grifols Therapeutics LLC | 2014-10-01 |
| Down Syndrome Memantine Follow-up Study (NCT02304302) | University Hospitals Cleveland Medical Center | 2014-10-01 |
| A Minimally-invasive Approach to Cytoreduction and HIPEC for Peritoneal Surface Malignancy (NCT02463877) | University of California, San Diego | 2014-10-01 |
| Home-based Balance Training Using Wii Fit After Stroke: A Feasibility Study (NCT02251470) | Martin-Luther-Universität Halle-Wittenberg | 2014-10-01 |
| Treatment-free Remission Accomplished With Dasatinib in Patients With CML (NCT02268370) | University Health Network, Toronto | 2014-10-01 |
| The Efficacy and Safety of the 1,414 nm Nd:YAG Laser System for Alleviating Back Pain in a Lumbar Disc Patient (NCT02598232) | CynosureLutronic | 2014-10-01 |
| Addition of Enzalutamide to First Line Docetaxel for Castration Resistant Prostate Cancer (NCT02453009) | Santa Chiara Hospital | 2014-10-01 |
| The Addition of Nab-paclitaxel (Abraxane) to First Line Treatment of Metastasized Oesophagogastric Carcinoma (ACTION) (NCT02273713) | Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA) | 2014-10-01 |
| Efficacy and Safety of 4-aminopyridine on Cognitive Performance and Motor Function of Patients With Multiple Sclerosis (NCT02280096) | Coordinación de Investigación en Salud, Mexico | 2014-10-01 |
| Stem Cell Transplantation for Stiff Person Syndrome (SPS) (NCT02282514) | Northwestern University | 2014-10-01 |
| "MIRO" Molecularly Oriented Immuno-radio-therapy (NCT02710643) | Fondazione Italiana Linfomi - ETS | 2014-10-01 |
| A Clinical Trial on the Efficacy of a Combination Herbal Product, Biotropics' Nu Femme, on Menopausal Symptoms and Quality of Life in Women (NCT02269891) | KGK Science Inc. | 2014-10-01 |
| The GLOBAL Vitamin D Study. A Genomic, Transcriptomic, Proteomic and Metabolomic Approach (NCT02783924) | University of Tromso | 2014-10-01 |
| A Phase IIb Study of OligoG in Subjects With Cystic Fibrosis (NCT02157922) | AlgiPharma AS | 2014-10-01 |
| A Pharmacokinetic and Pharmacodynamic Study Comparing HLX01 And Rituximab in Patients With CD20-Positive, B-cell Lymphoma (NCT02584920) | Shanghai Henlius Biotech | 2014-10-01 |
| Study to See Whether Breath-Hold Techniques During RT Are Effective in Helping to Improve Sparing of the Heart (NCT02052102) | AHS Cancer Control Alberta | 2014-10-01 |
| Biological Medicine for Diffuse Intrinsic Pontine Glioma (DIPG) Eradication (NCT02233049) | Gustave Roussy, Cancer Campus, Grand Paris | 2014-10-01 |
| Effects of Zinc Supplementation on Anthropometric Factors, Apelin and Inflammatory Markers in Obese Individuals (NCT02516475) | National Nutrition and Food Technology Institute | 2014-10-01 |
| Comparative Study of Prophylactic Agent for Venous Thromboembolism After Total Knee Arthroplasty (NCT02271399) | Hanyang University Seoul Hospital | 2014-10-01 |
| Recombinant Human Endostatin Adenovirus Combined With Chemotherapy for Advanced Head and Neck Malignant Tumors (NCT02283489) | Renmiao Zhang | 2014-10-01 |
| A Clinical Trial to Evaluate Efficacy, Tolerability, and Pharmacokinetic-Pharmacodynamic Relationship of Fimasartan/Hydrochlorothiazide (NCT02222480) | Boryung Pharmaceutical Co., Ltd | 2014-10-01 |
| Closed-loop Control of Overnight Glucose Levels (Artificial Pancreas) in Type 1 Diabètes Adults With Hypoglycemia Unawareness and Documented Nocturnal Hypoglycemia (NCT02282254) | Institut de Recherches Cliniques de Montreal | 2014-10-01 |
| BOTOX® (Onabotulinumtoxin A) Injection(s) as a Treatment for Carpal Tunnel Syndrome (NCT02070302) | Benjamin Sucher | 2014-10-01 |
| Regorafenib Eye Drops: Investigation of Efficacy and Safety in Neovascular Age Related Macular Degeneration (NCT02222207) | Bayer | 2014-10-01 |
| Focal Brachytherapy in Patients With Selected "Low-risk" Prostate Cancer - a Phase-II-trial (NCT02391051) | University of Erlangen-Nürnberg Medical School | 2014-10-01 |
| A Parp Inhibitor (BMN 673) for Inoperable Advanced eNDometrial cAncer (NCT02127151) | University College, London | 2014-10-01 |
| TRIal evalUating the Menstrual and Ovarian Function of Young Breast Cancer Patients Treated With a cycloPHosphamide-free Regimen (NCT02053597) | Jules Bordet Institute | 2014-10-01 |
| Environmental Control as Add-on Therapy in Childhood Asthma (NCT02251379) | Johns Hopkins University | 2014-10-01 |
| Safety and Efficacy Study of MIS416 to Treat Secondary Progressive Multiple Sclerosis (NCT02228213) | Innate Immunotherapeutics | 2014-10-01 |
| Inhaled Sodium Nitrite on Heart Failure With Preserved Ejection Fraction (NCT02262078) | Mayo Clinic | 2014-10-01 |
| Plerixafor Plus Granulocyte Colony-stimulating Factor (G-CSF) For Mobilization And Collection Of Peripheral Hematopoietic Stem Cells In Japanese Participants With Multiple Myeloma (NCT02221479) | Genzyme, a Sanofi Company | 2014-10-01 |
| Study to Assess the Safety, Tolerability, and Pharmacodynamic (PD) Effects of FRM-0334 in Subjects With Prodromal to Moderate Frontotemporal Dementia With Granulin Mutation (NCT02149160) | FORUM Pharmaceuticals Inc | 2014-10-01 |
| A Eurosarc Study of Mifamurtide in Advanced Osteosarcoma (MEMOS) (NCT02441309) | University of Oxford | 2014-10-01 |
| PK Study of Sildenafil in Neonate (NCT02244528) | Seoul National University Hospital | 2014-10-01 |
| A Phase Ⅱ Study of XELOX Chemotherapy With or Without Surgery of Primary Lesion for Colon Cancer Patients (NCT02291744) | Fudan University | 2014-10-01 |
| Effects of Genmont Probiotic on Improve the Level of Blood Glucose and Other Diabetic Associate Parameter in Type 2 Diabetes Patients (NCT02274272) | GenMont Biotech Incorporation | 2014-10-01 |
| Labor Induction and Maternal BMI, Comparison of Different Pre-induction Cervical Ripening Methods (NCT02223949) | Hillel Yaffe Medical Center | 2014-10-01 |
| A Phase 2 Study to Evaluate the Safety and Efficacy of CB-03-01 Solution, a Comparator Solution and Vehicle Solution in Males With Androgenetic Alopecia (NCT02279823) | Intrepid Therapeutics, Inc. | 2014-10-01 |
| Doxycycline to Upgrade Organ Response in Light Chain (AL) Amyloidosis Trial (NCT02207556) | Medical College of Wisconsin | 2014-10-01 |
| Phase II Safety and Acceptability of an Investigational Injectable Product, TMC278LA, for Pre-Exposure Prophylaxis (NCT02165202) | PATH | 2014-10-01 |
| A Prospective, Multi-center Trial for Reinforced Staple During Distal Pancreatectomy (NCT02270554) | Wakayama Medical University | 2014-10-01 |
| Randomized Phase IIb Trial of DVC1-0101 (NCT02276937) | Kyushu University | 2014-10-01 |
| Respiratory Mechanics and Metabolic Changes During Low Pressure Laparoscopic Cholecystectomy (NCT02469831) | Assiut University | 2014-10-01 |
| Impact of Physical Therapy Program in Mouthbreathing Children After Adenotonsillectomy (NCT02373553) | Federal University of Minas Gerais | 2014-10-01 |
| Placebo-Controlled Evaluation of Intranasal Dexmedetomidine for Postoperative Analgesia Following Bunionectomy Surgery (NCT02284243) | Baudax Bio | 2014-10-01 |
| Pilot Study of the Effectiveness of Probiotics and Lactitol for the Decolonization of OXA-48 (Carbapenemase) Producing Klebsiella Pneumoniae Among Rectal Carriers (NCT02307383) | Instituto de Investigación Hospital Universitario La Paz | 2014-10-01 |
| BOTOX® Efficacy and Safety in the Treatment of Knee Osteoarthritis (NCT02230956) | Allergan | 2014-10-01 |
| Study on the Use of Low Dose Ketamine After Gastric Bypass and Gastrectomy (NCT02452060) | NYU Langone Health | 2014-10-01 |
| Trial of IW-9179 in Patients With Diabetic Gastroparesis (DGP) (NCT02289846) | Ironwood Pharmaceuticals, Inc. | 2014-10-01 |
| Pilot Study to Examine the Use of Rivaroxaban After Angioplasty for Critical Limb Ischemia (NCT02260622) | Ottawa Hospital Research Institute | 2014-10-01 |
| A 1-Year Safety Study of OTO-104 in Subjects With Unilateral Meniere's Disease Located in United Kingdom (NCT02265393) | Otonomy, Inc. | 2014-10-01 |
| Safety, Tolerability, and Immunoregulatory Activity of Mogamulizumab (KW-0761) in Subjects With Advanced and/or Metastatic Solid Tumors (NCT02281409) | Memorial Sloan Kettering Cancer Center | 2014-10-01 |
| Efficacy and Safety of Aflibercept in Combination With FOLFIRI Chemotherapy as 1st Line Treatment for Patients With Metastatic Colorectal Cancer (NCT02181556) | Federation Francophone de Cancerologie Digestive | 2014-10-01 |
| Clomiphene Citrate in Combination With Gonadotropins for Ovarian Stimulation in Women With Poor Ovarian Response. (NCT02237755) | University of Athens | 2014-10-01 |
| A Extension Study to Evaluate Revusiran (ALN-TTRSC) in Patients With Transthyretin (TTR) Cardiac Amyloidosis (NCT02292186) | Alnylam Pharmaceuticals | 2014-10-01 |
| An Efficacy, Safety and Pharmacokinetics Study of Simeprevir, Daclatasvir and Sofosbuvir in Participants With Chronic Hepatitis C Virus Genotype 1 or 4 Infection and Decompensated Liver Disease (NCT02262728) | Janssen Research & Development, LLC | 2014-09-30 |
| Dendritic Cell-based Immunotherapy for Advanced Solid Tumours of Children and Young Adults (NCT02496520) | Clinica Universidad de Navarra, Universidad de Navarra | 2014-09-30 |
| Early Signs of Efficacy Study With Riociguat in Adult Homozygous Delta F508 Cystic Fibrosis Patients (NCT02170025) | Bayer | 2014-09-30 |
| Omalizumab in Severe and Refractory Solar Urticaria (NCT02262130) | Centre Hospitalier Universitaire de Besancon | 2014-09-30 |
| An Efficacy and Safety Study of Lanabecestat (LY3314814) in Early Alzheimer's Disease (NCT02245737) | AstraZeneca | 2014-09-30 |
| Social Intelligence Training in Midlife (NCT03824353) | Arizona State University | 2014-09-30 |
| An Investigational Immuno-therapy Study to Determine the Safety of Urelumab Given in Combination With Nivolumab in Solid Tumors and B-cell Non-Hodgkin's Lymphoma (NCT02253992) | Bristol-Myers Squibb | 2014-09-29 |
| Botulinum Toxin for Cramps in Diabetic Neuropathy (NCT03238898) | Presidio Ospedaliero Garibaldi-Centro | 2014-09-27 |
| Trial of Hypofractionated Radiation Therapy for Glioblastoma (NCT02206230) | AHS Cancer Control Alberta | 2014-09-25 |
| Study of Itacitinib in Combination With Docetaxel in Subjects With Non-Small Cell Lung Cancer (NCT02257619) | Incyte Corporation | 2014-09-24 |
| A Study to Monitor the Safety of Enzalutamide in Patients With Progressive Castration-Resistant Prostate Cancer Previously Treated With Docetaxel-Based Chemotherapy (NCT02124668) | Astellas Pharma Europe B.V. | 2014-09-23 |
| Evaluate SAGE-547 in Participants With Essential Tremor (NCT02277106) | Sage Therapeutics | 2014-09-23 |
| Selinexor (KPT-330) and Liposomal Doxorubicin For Relapsed and Refractory Multiple Myeloma (NCT02186834) | H. Lee Moffitt Cancer Center and Research Institute | 2014-09-23 |
| Study of Abiraterone Acetate in Participants With Metastatic Castration-Resistant Prostate Cancer (mCRPC), Chemo-Naive, Who Received a Prior Diethylstilbestrol Therapy (NCT02217566) | Janssen Research & Development, LLC | 2014-09-23 |
| Study of the Efficacy and Safety of Immune Globulin Intravenous (Human) Flebogamma® 5% Dual Inactivation and Filtration (DIF) in Participants With Post-polio Syndrome (NCT02176863) | Instituto Grifols, S.A. | 2014-09-23 |
| Robotic Surgery for Oropharyngeal Squamous Cell Carcinoma (NCT02225496) | M.D. Anderson Cancer Center | 2014-09-23 |
| Study of the Efficacy and Tolerability of Intravitreal Injections of Ranibizumab Compared to Intravitreal Injections of Ranibizumab Combined With Targeted Retinal Photocoagulation to Treat Radiation Retinopathy. (NCT02222610) | Greater Houston Retina Research | 2014-09-23 |
| Neoadjuvant Phase 2 Study Comparing the Effects of AR Inhibition With/Without SRC or MEK Inhibition in Prostate Cancer (NCT01990196) | Jonsson Comprehensive Cancer Center | 2014-09-23 |
| Evaluation of Tolcapone as a Cognitive Enhancer in Schizophrenia (NCT06387771) | Clinica Universidad de Navarra, Universidad de Navarra | 2014-09-22 |
| Androxal in Male Infertility (NCT02160704) | Baylor College of Medicine | 2014-09-22 |
| Selinexor Treatment of Advanced Relapsed/Refractory Squamous Cell Carcinomas (NCT02213133) | Karyopharm Therapeutics Inc | 2014-09-22 |
| Study Evaluating Venetoclax in Subjects With Hematological Malignancies (NCT02265731) | AbbVie | 2014-09-22 |
| Nab-paclitaxel and Carboplatin Followed by Response-Based Local Therapy in Treating Patients With Stage III or IV HPV-Related Oropharyngeal Cancer (NCT02258659) | University of Chicago | 2014-09-22 |
| Testing Two Different Treatment Schedules of Dabrafenib and Trametinib for Skin Cancer Which Has Spread (NCT02196181) | National Cancer Institute (NCI) | 2014-09-19 |
| Effects of Folfirinox and Stereotactic Body Radiation Therapy for Advanced Pancreatic Cancer (NCT02128100) | University of Louisville | 2014-09-19 |
| A Study to Evaluate the Efficacy, Safety, and Pharmacokinetics of Co-Administration of ABT-493 and ABT-530 With and Without RBV in Subjects With Chronic Hepatitis C Virus (HCV) Genotypes 2, 3, 4, 5 or 6 Infection (NCT02243293) | AbbVie | 2014-09-19 |
| Adjuvant Anti-Mineralocorticoid-Receptor Treatment in Anti-VEGF Refractory Neovascular Age-Related Macular Degeneration (NCT03744767) | Dr Irmela MANTEL | 2014-09-19 |
| Efficacy and Safety Study of Cenicriviroc for the Treatment of Nonalcoholic Steatohepatitis (NASH) in Adult Participants With Liver Fibrosis (NCT02217475) | Tobira Therapeutics, Inc. | 2014-09-18 |
| FMT Delivered by Capsule Versus Colonoscopy for Recurrent C. Diff (NCT02254811) | University of Alberta | 2014-09-18 |
| Ceritinib (LDK378) for Patients Whose Tumors Have Aberrations in ALK or ROS1 (SIGNATURE) (NCT02186821) | Novartis Pharmaceuticals | 2014-09-17 |
| Prophylactic Ranibizumab for Exudative Age-related Macular Degeneration (NCT02140151) | Southern California Desert Retina Consultants, MC | 2014-09-17 |
| Treatment for Bile Duct Cancer in the Liver (NCT02167711) | Chinese University of Hong Kong | 2014-09-17 |
| Study of Efficacy and Safety of Bimagrumab in Patients After Hip Fracture Surgery (NCT02152761) | Novartis Pharmaceuticals | 2014-09-16 |
| A Pilot Study of CC-220 to Treat Systemic Lupus Erythematosus. (NCT02185040) | Celgene | 2014-09-16 |
| Evaluation of Oncoxin-Viusid® in Cutaneous Melanoma (NCT03541148) | Catalysis SL | 2014-09-16 |
| Improving Therapeutic Learning in Depression: Proof of Concept (NCT02376257) | Boston University Charles River Campus | 2014-09-16 |
| Prospective Evaluation of the Efficacy of Sirolimus (Rapamune®) in the Treatment of Severe Arteriovenous Malformations (NCT02042326) | Centre Hospitalier Universitaire, Amiens | 2014-09-12 |
| Effect of Beetroot Juice on Blood Pressure Regulation in Post Menopausal Women (NCT03380000) | Penn State University | 2014-09-12 |
| Phase II Study to Evaluate Overall Response in Patients With Higher Risk Myelodysplastic Syndromes (MDS) Treated With Azacitidine With or Without Deferasirox. (NCT02159040) | Novartis Pharmaceuticals | 2014-09-11 |
| An Open-label, Phase 2 Study of ACP-196 in Subjects With Waldenström Macroglobulinemia (NCT02180724) | Acerta Pharma BV | 2014-09-11 |
| A Pharmacokinetic (PK) and Pharmacodynamic (PD) Dose-ranging Phase II Study of Ticagrelor in Paediatric Patients With Sickle Cell Disease (NCT02214121) | AstraZeneca | 2014-09-11 |
| A Phase 2 Open-Label Study of the Efficacy and Safety of ABT-199 (GDC-0199) in Chronic Lymphocytic Leukemia (CLL) Subjects With Relapse or Refractory to B-Cell Receptor Signaling Pathway Inhibitor Therapy (NCT02141282) | AbbVie | 2014-09-10 |
| 16-Week Repeat Oral Dose Study of AKB-6548 for Anemia in Participants With End Stage Renal Disease (ESRD) Requiring Chronic Hemodialysis (NCT02260193) | Akebia Therapeutics | 2014-09-10 |
| An Open-Label Study of a Novel JAK-inhibitor, INCB052793, Given to Patients With Advanced Malignancies (NCT02265510) | Incyte Corporation | 2014-09-10 |